Future directions for the discovery of natural product-derived immunomodulating drugs: an IUPHAR positional review

• Main Authors: Cherry L. Wainwright (Author), Mauro M. Teixeira (Author), David L. Adelson (Author), Fernão C. Braga (Author), Eric J. Buenz (Author), Priscilla R.V. Campana (Author), Bruno David (Author), Keith B. Glaser (Author), Yuka Harata-Lee (Author), Melanie-Jayne R. Howes (Author), Angelo A. Izzo (Author), Pasquale Maffia (Author), Alejandro M.S. Mayer (Author), Claire Mazars (Author), David J. Newman (Author), Eimear Nic Lughadha (Author), Rodrigo M. Pádua (Author), Adriano M.C. Pimenta (Author), John A.A. Parra (Author), Zhipeng Qu (Author), Hanyuan Shen (Author), Michael Spedding (Author), Jean-Luc Wolfender (Author)
• פורמט: ספר
• יצא לאור: Elsevier, 2022-03-01T00:00:00Z.
• נושאים: article
• גישה מקוונת: Connect to this object online.

Drug discovery from natural sources is going through a renaissance, having spent many decades in the shadow of synthetic molecule drug discovery, despite the fact that natural product-derived compounds occupy a much greater chemical space than those created through synthetic chemistry methods. With...